Loading...
Market
Recognition or award for AI-created treatment by end of 2025?
2
Resolution / Starting Odds
Nobel Prize • 25%
Breakthrough Prize • 25%
Lasker Award • 25%
No major award • 25%
Announcements from reputable awarding bodies or institutions
Story
AI Creates Experimental Treatment for Neglected Disease, Aiming to Democratize Drug Discovery by David Baker's Team
Jan 16, 2025, 12:08 PM
Researchers have developed an experimental treatment for a neglected disease using artificial intelligence, marking a significant advancement in drug discovery. The project, led by Nobel laureate David Baker and researcher Susana Vaz Torres, aims to 'democratize' the development of therapies that have been largely ignored by major pharmaceutical companies. This breakthrough was achieved through the application of AI technologies in the discovery process, showcasing the potential of AI to transform healthcare and address unmet medical needs.
View original story
Similar markets
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Yes • 50%
No • 50%
NVIDIA & Mayo Clinic • 25%
NVIDIA & Arc Institute • 25%
NVIDIA & IQVIA • 25%
NVIDIA & Illumina • 25%
Bacterial infections • 25%
Autoimmune diseases • 25%
Viral infections • 25%
Cancer treatment • 25%
